Supplementary Figure 1. Expression of inflammatory mediators CXCL10/IP10 and IL6 for samples and control. Experimental groups of subacute and acute phases for IP10 (A); experimental groups of subacute and acute phases for IL-6 (B); experimental groups of subacute and acute phases for IL-4 (C); experimental groups of subacute and acute phases for IL-5 (D); experimental groups of subacute and acute phases for IL-17a (E); experimental groups of subacute and acute phases for TNF-α (F) and …